Preservatives in eye drops: Toward awareness of their toxicity;Les conservateurs des collyres: Vers une prise de conscience de leur toxicité

Journal Francais d'Ophtalmologie

Volumn 33, Issue 7, 2010, Pages 505-524

  Vaede, D ^a   Baudouin, C ^b,c,d   Warnet, J M ^a,b   Brignole Baudouin, F ^a,b  

^a Centre Universitaire des Saints Pères   (France)

^b INSERM   (France)

^c CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Benzalkonium; Eyedrops; Glaucoma; Ocular surface; Preservatives; Toxicity

Indexed keywords

EYE DROPS; PRESERVATIVE;

ANIMAL; CHEMICALLY INDUCED DISORDER; EYE DISEASE; HUMAN; REVIEW;

ANIMALS; EYE DISEASES; HUMANS; OPHTHALMIC SOLUTIONS; PRESERVATIVES, PHARMACEUTICAL;

EID: 77957265904     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfo.2010.06.018     Document Type: Review

References (109)

1. C. Baudouin, A. Labbe, H. Liang, A. Pauly, and F. Brignole-Baudouin Preservatives in eyedrops: the good, the bad and the ugly Progr Ret Eye Res 29 2010 312 334
2. P. Gilbert, and L.E. Moore Cationic antiseptics: diversity of action under a common epithet J Appl Microbiol 99 2005 703 715
3. C.J. Ioannou, G.W. Hanlon, and S.P. Denyer Action of disinfectant quaternary ammonium compounds against Staphylococcus aureus Antimicrob Agents Chemother 51 2007 296 306
4. A. Labbé, A. Pauly, H. Liang, F. Brignole-Baudouin, C. Martin, and J.M. Warnet Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental study J Ocul Pharmacol Ther 22 2006 267 278
5. R.K. Rajpal, and S.R. Glaser Antiseptics and disinfectants K.S. Kooner, M. Sharir, Textbook of pharmacology 1997 Lipppincott-Raven Philadelphia 662 663
6. Rose FL, Swain G. Bisdiguanides having antibacterial activity. J Chem Soc. 1956; Part IV, 4422-4425. In: P. Broxton, PM, Woodcock PG. A study of the antibacterial activity of some polyhexamethylene biguanides towards Escherichia coli ATCC 8739". J Appl Microbiol 1983;54:345-53.
7. L.M. Hamed, F.D. Ellis, G. Boudreault, F.M. Wilson, and E.M. Helveston Hibiclens keratitis Am J Ophthalmol 104 1987 50 56
8. R.B. Phinney, B.J. Mondino, J.D. Hofbauer, D.M. Meisler, R.H. Langston, and S.L. Forstot Corneal edema related to accidental Hibiclens exposure Am J Ophthalmol 106 1988 210 215
9. P.D. Darbre, A. Aljarrah, W.R. Miller, N.G. Coldham, M.J. Sauer, and G.S. Pope Concentrations of parabens in human breast tumours J Appl Toxicol 24 2004 5 13 (Pubitemid 38181537)
10. P.D. Darbre, and P.W. Harvey Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks J Appl Toxicol 28 2008 561 578
11. O. Handa, S. Kokura, S. Adachi, T. Takagi, Y. Naito, and T. Tanigawa Methylparaben potentiates UV-induced damage of skin keratinocytes Toxicology 227 2006 62 72
12. P.R. Ingram, A.R. Pitt, C.G. Wilson, O. Olejnik, and C.M. Spickett A comparison of the effects of ocular preservatives on mammalian and microbial ATP and glutathione levels Free Radic Res 38 2004 739 750
13. I.P. Kaur, S. Lal, C. Rana, S. Kakkar, and H. Singh Ocular preservatives: associated risks and newer options Cutan Ocul Toxicol 28 2009 93 103
14. R.A. Lewis, G.J. Katz, M.J. Weiss, T.A. Landry, J.E. Dickerson, and J.E. James Travoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacy J Glaucoma 16 2007 98 103
15. C. Baudouin, L. Riancho, J.M. Warnet, and F. Brignole In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost Invest Ophthalmol Vis Sci 48 2007 4123 4128
16. M. Kahook, and R. Noecker Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofzia, latanoprost with 0,02% benzalkonium chloride, and preservative-free artificial tears Cornea 27 2008 339 343
17. H. Chibret Conservateurs et préparation ophtalmiques : réalités et perspectives Ann Pharm Fr 55 1997 228 231
18. Bonnard N, Brondeau MT, Falcy M, Protois JC, Schneider O. Fiche toxicologique 253, chlorure de benzalkonium. Institut national de recherche et de sécurité (INRS), 2005; http://www.inrs.fr.
19. D.L. Fredell Biological properties and applications of cationic surfactants J. Cross, E.J. Singer, Cationic surfactants 1994 Marcel Dekker New York 31 60
20. C. Debbasch, F. Brignole, P.J. Pisella, J.M. Warnet, P. Rat, and C. Baudouin Quaternary ammoniums and other preservatives contribution in oxidative stress and apoptosis on Chang conjunctival cells Invest Ophthalmol Vis Sci 41 2001 642 652
21. C. Debbasch, P.J. Pisella, M. De Saint Jean, P. Rat, J.M. Warnet, and C. Baudouin Mitochondrial activity and glutathione injury in apoptosis induced by unpreserved and preserved beta-blockers on Chang conjunctival cells Invest Ophthalmol Vis Sci 42 2001 2525 2533
22. J. Fleurette, J. Freney, and M.E. Reverdy Les ammoniums quaternaires Antisepsie et désinfection 1996 Ed ESKA p. 174-198
23. F. Ferk, M. Misík, T. Grummt, B. Majer, M. Fuerhacker, and C. Buchmann BAC and DDAB, two common quaternary ammonium compounds, cause genotoxic effects in mammalian and plant cells at environmentally relevant concentrations Invest Ophtalmol Vis Sci 48 2007 2001 2008
24. T. Deutschle, U. Pokert, R. Reiter, T. Keck, and H. Riechelmann In vitro genotoxycity and cytotoxycity of benzalkonium chloride Toxicol in Vitro 20 2006 1472 1477
25. M. Hitosugi, K. Maruyama, and A. Takastu A case of benzalkonium chloride poisoning.1 Int J Legal Med 111 1998 265 266
26. P. Graf BAC as a preservative in nasal solution: re-examinating the data Respir Med 95 2001 728 733
27. R. Mallants, M. Jorissen, and P. Augustijns Effect of preservatives on ciliary beat frequency in human nasal epithelial cell culture: single versus multiple exposure Int J Pharm 338 2007 64 69
28. C.Y. Ho, M.C. Wu, M.Y. Lan, C.T. Tan, and A.H. Yang In vitro effects of preservatives in nasal sprays on human nasal epithelial cells Am J Rhinol 22 2008 125 129
29. K. Hegstad, S. Langsrud, B.T. Lunestad, A.A. Scheie, M. Sunde, and S.P. Yazdankhah Does the wide use of quaternary ammonium compounds enhance the selection and spread of antimicrobial resistance and thus threaten our health? Microb Drug Resist 16 2010 91 104
30. K. Hegstad, S. Langsrud, B.T. Lunestad, A.A. Scheie, M. Sunde, and S.P. Yazdankhah Does the wide use of quaternary ammonium compounds enhance the selection and spread of antimicrobial resistance and thus threaten our health? Rob Drug Resist 16 2010 91 104
31. N.A. Romanova, P.F.G. Wolffs, L.Y. Brovko, and M.W. Griffiths Role of Efflux Pumps in Adaptation of Resistance of Listeria monocytogenes to benzalkonium chloride Applied Environ Microbiol 2006 3498 3503
32. B.V. Para, O. Nunez, E. Moyano, and M.T. Galceran Analysis of benzalkonium chloride by capillary electrophoresis tandem mass spectrometry Electrophoresis 27 2006 2225 2232
33. Y. Guo, M. Satpathy, G. Wilson, and S.P. Srinivas Benzalkonium chloride induces dephosphorilation of myosin light chain in cultured corneal epithelial cells Invest Ophthalmol Vis Sci 48 2007 2001 2008 (Pubitemid 351261267)
34. R.J. Marsh, S. Towns, and K.F. Evans Patch testing in ocular drug allergies Trans Ophthalmol Soc UK 98 1978 778 780
35. A. Tosti, L. Guerra, and F. Bardazzi Hyposenzitising therapie with standard antigenic extracts: an important source of thimerosal sensitzation Contact Dermatitis 20 1989 173 176
36. A. Hatinen, M. Terasvirta, and J.E. Fraki Contact allergy to components in topical ophthalmologic preparations Acta Ophthalmol 63 1985 424 426
37. Verin Ph, J. de Casamyor, P. Coulon, W. Williamson, B. Montemousque, and P.A. Ndiaye Que faire des malades allergiques au benzalkonium? Bull Soc Opht France 6-7 1992 589 592
38. N. Wilson-Holt, and J.K. Dart Thiomersal keratoconjunctivitis, frequency, clinical spectrum and diagnosis Eye 3 1989 581 587
39. N.L. Burstein Corneal cytotoxicity of topically applied drugs, vehicles and preservatives Surv Ophthalmol 25 1980 15 30
40. M.B. Abelson, and K. Schaefer Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy Surv Ophthalmol 38 Suppl 1993 115 132
41. C.L. Goh Contact sensitivity to topical antimicrobials (II). Sensitizing potentials of some topical antimicrobials Contact Dermatitis 21 1989 166 171
42. M.G. Baines, F. Cai, and H.A. Backman Ocular hypersensivity to thimerosal in rabbits Invest Ophthalmol Vis Sci 32 1991 2259 2265
43. J.R. Samples, P.S. Binder, and S. Nayak The effect of epinephrine and benzalkonium chloride on cultured corneal endothelial and trabecular meshmork cells Exp Eye Res 49 1989 1 12
44. P. Lapalus, M. Ettaiche, D. Fredj-Reygrobelet, D. Jambou, and P.P. Elena Cytotoxy studies in ophthalmology Lens Eye Toxic Res 7 1990 231 242
45. P.P. Parnigotto, V. Bassani, F. Montesi, and M.T. Conconi Bovine corneal stroma and epithelium reconstructed in vitro: characterisation and response to surfactants Eye 12 1998 304 310
46. D.E. Williams N Guyen KD, Shapourifar-Tehrani S, Kitada S Lee DA. Effects of timolol, betaxolol, and levobutonolol on human tenon's fibroblasts in tissue culture. Invest Ophthalmol Vis Sci 33 1992 2233 22341
47. Y. Goto, N. Ibaraki, and K. Miyake Human lens epithelial cell damage and stimulation of their secretion of chemical mediators by benzalkonium chloride rather than latanoprost and timolol Arch Ophthalmol 121 2003 835 839
48. P. Saarinen-Savolainen, T. Jarvinen, K. Araki-Sasaki, H. Watanabe, and A. Urtii Evaluation of cytoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line Pharm Res 15 1998 1275 1280
49. M. De Saint Jean, F. Brignole, A.F. Bringuier, A. Bauchet, G. Feldmann, and C. Baudouin Effects of benzalkonium chloride on growth and survival of Chang conjonctival cells Invest Ophtalmol Vis Sci 40 1999 619 630
50. P.S. Imperia, H.M. Lazarus, R.E. Botti, and J.H. Lass An in vitro method for measuring ophthalmic preservative cytotoxicity J Toxicol Cut Ocular 5 1986 309 317
51. H.M. Lazarus, P.S. Imperia, R.E. Botti, R.J. Mack, and J.H. Lass An in vitro method which accesses corneal epithelial toxicity due to antineoplastic, preservative and antimicrobial agents Lens eye Toxic Res 6 1989 59 85
52. R. Mencucci, M. Scivanti, A. Crisa, and G. Salvi La culture d'épithélium cornéen humain et les conservateurs pour solution usage ophtalmique Ophtalmologie 10 1996 13 15
53. A. Pauly, M. Meloni, F. Brignole-Baudouin, J.M. Warnet, and C. Baudouin Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage Invest Ophthalmol Vis Sci 50 2009 1644 1652
54. E.M. Salonen, A. Vaheri, T. Tervo, and R. Beuerman Toxicity of ingredients in artificial tears ancd ophthalmic drugs in a cell attachment and spreading test J Toxicol Cutan Ocul Toxicol 10 1991 157 166
55. M. De Saint Jean, C. Debbasch, F. Brignole, P. Rat, J.M. Warnet, and C. Baudouin Cytotoxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells Curr Eye Res 20 2000 85 94 (Pubitemid 30099159)
56. N. Takahashi Quantitative cytotoxicity of preservative evaluated in cell culture with Chang's human conjunctival cells Effects of temperature on cytotoxicity. Jpn J Ophthalmol 26 1982 234 238
57. B.J. Tripathi, R.C. Tripathi, and S.P. Kolli Cytotoxy of ophthalmic preservatives on human corneal epithelium Lens Eye Toxic Res 9 1992 361 375
58. C. Debbasch, S.B. De La Salle, F. Brignole, P. Rat, J.M. Warnet, and C. Baudouin Cytoprotective effects of hyaluronic acid and Carbomer 934P in ocular surface epithelial cells Invest. Ophthalmol Vis Sci 43 2002 3409 3415
59. B.J. Tripathi, and R.C. Tripathi Cytotoxic effects of benzalkonium chloride and chlorobutanol on human corneal epithelial cells in vitro Lens Eye Toxic Res 6 1989 395 403
60. M.S. Norn Role of the vehicle in local treatment of the eye Acta Ophthalmol 42 1964 727 734
61. D. Monti, P. Chetoni, S. Burgalassi, M. Najarro, and M.F. Saettone Increased corneal hydration induced by potential ocular penetration enhancers: assessment by differential scanning calorimetry (DSC) and by dessication Int J Pharm 232 2002 139 147
62. J.V. Jester, J.K. Maurer, W.M. Petroll, D.A. Wilkie, R.D. Parker, and H.D. Cavanagh Application of in vivo confocal microscopy to the understanding of surfactant induced ocular irritation Toxicol Pathol 24 1996 412 428
63. A. Pauly, F. Brignole-Baudouin, A. Labbé, H. Liang, J.M. Warnet, and C. Baudouin New tools for the evaluation of toxic ocular surface changes in the rat Invest Ophthalmol Vis Sci 48 2007 5473 5483
64. H. Liang, C. Baudouin, M.O. Faure, G. Lambert, and F. Brignole-Baudouin Comparison of the ocular tolerability of a latanoprost cationic emulsion versus conventional formulations of prostaglandins: an in vivo toxicity assay Mol Vis 15 2009 1690 1699
65. H. Liang, C. Baudouin, B. Dupas, and F. Brignole-Baudouin Live conjunctiva-associated lymphoid tissue analysis in rabbit under inflammatory stimuli using in vivo confocal microscopy Invest Ophthalmol Vis Sci 51 2010 1008 1015
66. R.L. Grant, and D. Acosta Prolonged adverse effects of benzalkonium chloride and sodium dodecyl sulfate in a primary culture system of rabbit corneal epithelial cells Fundam Appl Toxicol 33 1996 71 82
67. C. Baudouin, P.J. Pisella, K. Fillacier, M. Goldschild, F. Becquet, and M. De Saint-Jean Ocular surface inflammatory changes induced by topical antiglaucoma drugs. Human and animal studies Ophthalmology 106 1999 556 563
68. C. Baudouin, C. Garcher, N. Haouat, A. Bron, and P. Gastaud Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma Ophthalmology 101 1994 454 460
69. C. Baudouin, P. Hamard, H. Liang, C. Creuzot-Garcher, L. Bensoussan, and F. Brignole Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term Ophthalmology 111 2004 2186 2192
70. W.S. Wilson, A.J. Ducan, and J.L. Jay Effect of benzalkonium chloride on the stability on the precorneal tear film in rabbit and man Br J Ophthalmol 59 1975 667 669
71. A. Ludwig, and M. Van Ooteghem Influence of the surface tension of eye drops on the retention of a tracer in the precorneal area of human eyes J Pharm Belg 43 1988 157 162
72. T. Kaercher, D. Honig, and W. Barth How the most common preservative effects the Meibomian lipid layer Orbit 18 1999 87 89
73. P.J. Pisella, K. Fillacier, P.P. Elena, C. Debbash, and C. Baudouin Comparison of the effects of preserved and unpreserved formulations of Timolol on the ocular surface of albino rabbits Ophthalmic Res 32 2000 3 8
74. W. Bernauer, D.C. Broadway, and P. Wright Chronic progressive conjunctival cicatrisation Eye 7 1993 371 378
75. I.S. Yalva, G. Gedikoglu, Y. Karagoz, U. Akgun, A. Nurozler, and F. Ko Effects of antiglaucoma drugs on ocular surface Acta Ophthalmol Scand 73 1995 246 248
76. F. Becquet, M. Goldschild, M.S. Moldovan, M. Ettaiche, P. Gastaud, and C. Baudouin Histopathological effect preservatives on rat corneoconjonctival surface Curr Eye Res 17 1998 419 425
77. E. Champeau, and H. Edelhauser Effect of ophthalmic preservatives on the ocular surface: conjunctival and corneal uptake and distribution of benzalkonium chloride and chlorhexidine digluconate F. Holly, The preocular tear film. 1986 Dry Eye Institute, Inc Lubbock, TX
78. R.J. Noecker, L.A. Herrygers, and R. Anwaruddin Corneal and conjunctival changes caused by commonly used glaucoma medications Cornea 23 2004 490 496
79. H. Mietz, U. Schlotzer-Schrehardt, J.H. Lemke, and G.K. Kriegstein Early conjuctival changes following treatment with metipranolol and preservatives are not reversible with dexamethasone Graefe's Arch Clin Exp Ophthalmol 235 1997 452 459
80. H. Mietz, U. Niesen, and G.K. Kriegstein The effects of preservatives and antiglaucomatous medication on the histopathology of the conjunctiva Graefe's Arch Clin Exp Ophthalmol 232 1994 561 565
81. T.L. Young, E.J. Higgimbotham, X.L. Zou, and M.D. Farber Effects on topical glaucoma drugs on fistulized rabbit conjunctiva Ophthalmology 97 1990 1423 1427
82. T.J. Liesegang Conjunctival changes associated with glaucoma therapy: implications for the external disease consultant and the treatment of glaucoma Cornea 17 1998 574 583
83. J.D. Brandt, J.R. Wittpenn, J. Katz, W.N. Steimann, and G.L. Spaeth Conjunctival impression cytology patients with glaucoma using long-term topical medication Am J Ophthalmol 112 1991 297 301
84. C. Costagliola, A.D. Prete, C. Incorvaia, R. Fusco, and F. Parmeggiani Di Giovanni A Ocular surface changes induced by topical application of latanoprost and timolol: a short-term study in glaucomatous patients with and without allergic conjunctivis. Graefes Arch Clin Exp Ophthalmol 239 2001 809 814
85. E. Turali, K. Budak, A. Kaur, B. Mizrak, and C. Ekinci The effects of long-term topical glaucoma medication on conjunctival impression cytology Int Ophthalmol 21 1997 27 33
86. R. Nuzzi, C. Finazzo, and A. Cerruti Adverse effects of topical antiglaucomatous medications on the conjunctiva and the lachrymal response Int Ophthalmol 22 1998 31 35
87. M.B. Sherwood, I. Grierson, L. Millar, and R.A. Hitchings Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients Ophthalmology 96 1989 327 335
88. I.R. Schwab, J.V. Linberg, V.M. Gioia, W.H. Benson, and G.M. Chao Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications Ophthalmology 99 1992 197 202
89. P. Furrer, M. Mayer, B. Plazonnet, and R. Gurny Ocular tolerance of preservatives on the murine cornea Eur J Pharm Biopharm 47 1999 105 112
90. P. Furrer, J. Berger, J.M. Mayer, and R. Gurny Etude comparative de la tolérance oculaire de 3 spécialités base de timolol : influence du conservateur sur la tolérance oculaire J Fr Ophtalmol 24 2001 13 19
91. M. Imayasu, T. Moriyama, J. Ohashi, H. Ichijima, and H.D. Cavanagh A quantitative method for LDH MDH and albumin levels in tears with ocular surface toxicity scored by Draize criteria in rabbit eyes. CLAO J 18 1992 260 266
92. D. Lopez Bernal, and J.L. Ubels Quantitative evaluation of the corneal epithelial barrier: effect of articicial tears and preservatives Curr Eye Res 10 1991 645 656
93. D.V. Hendrix, D.A. Ward, and M.A. Barnhill Effects of anti-inflammatory drugs and preservatives on morphologic characteristics and migration of cabine corneal epithelial cells in tissue culture Vet Ophthalmol 5 2002 127 135
94. H.B. Collin, and B.E. Grabsch The effect of ophthalmic preservatives on the heating rate of the rabbit corneal epithelium after keratectomy Am J Optom Physiol Optics 59 1982 215 222
95. H. Klip, B. Heisig-Salentin, W. Poss, C. Thode, and K. Rogalla Acute and chronic influence of benzalkonium chloride as a preservative Concepts Toxicol 4 1987 59 63
96. M.A. Lemp, and L.E. Zimmerman Toxic endothelial degeneration in ocular surface disease treated with topical medications containing benzalkonium chloride Am J Ophthalmol 105 1988 670 673
97. G.R. Manecke Jr., D.P. Tannenbaum, and B.E. McCoy Severe bilateral corneal injury attributed to a preservative-containing eye lubricant Anesthesiology 93 2000 1545 1546
98. H. Liu, I. Routley, and K.D. Teichmann Toxic endothelial cell destruction from intraocular benzalkonium chloride J Cataract Refract Surg 27 2001 1746 1750
99. H. Eleftheriadis, M. Cheong, S. Sandeman, P.P. Syam, P. Brittain, and G.K. Klintworth Corneal toxicity secondary to inadvertent use of benzalkonium chloride preserved viscoelastic material in cataract surgery Br J Ophthalmol 86 2002 299 305 (Pubitemid 34206344)
100. D.C. Broadway, I. Grierson, C. O'Brien, and R.A. Hitchings Adverse effects of topical antiglaucoma medication II. The outcome of filtration surgery. Arch Ophthalmol 112 1994 1446 1454
101. D. Broadway, I. Grierson, and R. Hitchings Topical antiglaucomatous therapy: adverse effects on the conjunctiva and implications for filtration surgery J Glaucoma 4 1995 136 148
102. M.J. Lavin, R.P.L. Wormald, C.S. Migdal, and R.A. Hitchings The influence of prior therapy on the success of trabeculectomy Arch Ophthalmol 108 1990 1543 1548
103. D. Broadway, I. Grieson, and R. Hitchings Adverse effects of topical antiglaucomatous medications on the conjunctiva Br J Ophthalmol 77 1993 590 596 (Pubitemid 23281461)
104. C. Baudouin Mecanisms of failure in glaucoma filtering surgery: a consequence of antiglaucoma drugs? Int J Clin Pharm Res 16 1996 29 41
105. P. Hamard, C. Blondin, C. Debbasch, J.M. Warnet, C. Baudouin, and F. Brignole In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells Graefes Arch Clin Exp Ophthalmol 241 2003 1037 1043
106. J.D. Brandt Does benzalkonium chloride cause cataract? Arch Ophthalmol 121 2003 892 893
107. K. Miyake, N. Ibaraki, Y. Goto, S. Oogiya, J. Ishigaki, and I. Ota ESCRS Binkhorst lecture 2002: pseudophakic preservative maculopathy J Cataract Refract Surg 29 2003 1800 1810
108. A. Chou, S. Hori, and M. Takase Ocular toxicity of beta-blockers and benzalkonium chloride in pigmented rabbits: electrophysiological and morphological studies Jpn J Ophthalmol 29 1985 13 23
109. T. Pauloin, M. Dutot, J.M. Warnet, and P. Rat In vitro modulation of préservative toxicity: high molecular weight hyaluronan decreases apoptosis and oxidative stress induced by benzalkonium chloride Eur J Pharm Sci 34 2008 263 273